Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer


ÇAĞLAR TUNCALI M. , Bozkurt F. M. , KAPULU AKÇA C. D. , Vargol S. E. , BAYRAKTAR M. , UĞUR Ö. , ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.33, sa.3, ss.268-274, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 33 Konu: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1097/mnm.0b013e32834ec5d6
  • Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
  • Sayfa Sayıları: ss.268-274

Özet

Introduction The initial treatment of differentiated thyroid cancer is thyroidectomy, followed by remnant ablation with iodine-131 (I-131) in some patients. However, controversy exists concerning the appropriate radioiodine dose. The aim of the study is to compare the success rate of low and high activities of I-131 for postoperative remnant ablation.